1. The economic burden of Clostridium difficile
S.M. McGlone, R.R. Bailey, S.M. Zimmer, M.J. Popovich, Y. Tian, P. Ufberg, R.R. Muder, B.Y. Lee 
Clinical Microbiology and Infection 
Volume 18, Issue 3, Pages (March 2012)
DOI: /j x
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
General decision model tree structure. *Give Tapered Vanomycin. ♦Use treatment strategy that was effective for prior episode. Treatment change: from metronidazole to vancomycin; no treatment change for vancomycin.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2
Tornado diagrams showing the effect of each variable on the cost per CDI case from (a) the hospital perspective, (b) the third-party payer perspective, and (c) the societal perspective.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions